AGM Statement

Advanced Medical Solutions Grp PLC 19 May 2004 For Immediate Release Wednesday 19th May 2004 Advanced Medical Solutions Group plc Annual General Meeting Statement Winsford, UK: Advanced Medical Solutions (AIM: AMS), the global woundcare technology company, is holding its Annual General Meeting at 11:00 am today. Don Evans, Chief Executive, will give a business update presentation, a copy of which is posted on the web site www.admedsol.com. Commenting on current trading, Chairman Dr. Geoffrey Vernon stated: 'The outlook for 2004 is positive. The strong start to the year has continued into the 2nd quarter and we remain on track to come through to profitability within current cash in line with market expectations.' -ENDS- For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508 Don Evans, Chief Executive Mary Tavener, Finance Director www.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000 Mark Court, Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a leading company in the development and manufacture of products for the $15 billion global woundcare market. Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative and technologically advanced products for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advanced wound dressings based on the moist healing principle. AMS's resources ensure a unique position as a vertically integrated 'one stop shop' to provide all categories of moist wound healing products. The Company has the capability to move from product design and development through to production and delivery ready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology in cyanoacrylate based tissue adhesives and sealants sold direct to hospitals or through distributors. AMS's technology and products currently serve the majority of the key global markets with strategic partners including 3M, Novartis, Johnson & Johnson Inc, Molnlycke Healthcare, Coloplast, Smith & Nephew and Beiersdorf. -------------------------- This information is provided by RNS The company news service from the London Stock Exchange
UK 100